Chinese researchers have built a machine-learning nomogram that combines biparametric MRI radiomics, clinical variables, and ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

A systematic review of eight studies finds that higher prostate MRI quality shows inconsistent and very-low-certainty associations with the confirmation of clinically significant prostate cancer among ...

Omitting biopsy in patients with a negative prostate MRI more than halves the diagnoses of clinically insignificant prostate cancer. Detection of clinically insignificant ISUP grade group 1 prostate ...

Prostate cancer is the second most commonly diagnosed cancer among men worldwide, with an estimated 1.55 million new cases in ...

Prostate cancer is the second-leading cause of cancer deaths in American men. Further, non-Hispanic Blacks have a higher incidence of prostate cancer and are more likely to die from it than are ...

Robert Uzzo, MD, MBA, of Fox Chase Cancer Center discusses an evolution in prostate cancer screening modalities.

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...

HT Health Talk: Prostate cancer is common but often silent. Should you get checked earlier if your father or brother had it?

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

Incorporating a polygenic risk score into prostate cancer screening could enhance the detection of clinically significant prostate cancer that conventional screening may miss, according to results of ...